Published in Asian J Androl on November 28, 2011
Relationship between the two surgical access of aortoiliac occlusive disease and recovery of ED. Int J Impot Res (2014) 0.83
Impaired flow-mediated vasodilatation in Asian Indians with erectile dysfunction. Asian J Androl (2013) 0.80
Erectile dysfunction and subsequent cardiovascular disease. JAMA (2005) 6.22
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol (2003) 3.23
Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol (2004) 3.12
Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J (2006) 2.91
Prevalence and risk factors for erectile dysfunction in the US. Am J Med (2007) 2.84
Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med (2000) 2.16
A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc (2009) 1.98
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. Eur Urol (2006) 1.82
Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients. Int J Clin Pract (2007) 1.69
Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol (2008) 1.67
Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol (2008) 1.57
Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol (2005) 1.45
Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder? Eur Urol (2003) 1.37
Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract (2010) 1.23
Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score? J Am Coll Cardiol (2010) 1.19
Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study. J Sex Med (2009) 1.16
Erectile dysfunction in the cardiac patient: how common and should we treat? J Urol (2003) 1.14
Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study. Int J Impot Res (2007) 1.14
Relation of erectile dysfunction to angiographic coronary artery disease. Am J Cardiol (2003) 1.10
Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol (2003) 1.08
The triad: erectile dysfunction--endothelial dysfunction--cardiovascular disease. Curr Pharm Des (2008) 1.06
The temporal relationship between erectile dysfunction and cardiovascular disease. Int J Clin Pract (2007) 1.03
Men's Health Study: epidemiology of erectile dysfunction and cardiovascular disease. Circ J (2003) 1.00
Erectile dysfunction severity as a risk predictor for coronary artery disease. J Sex Med (2009) 0.98
Incidence of erectile dysfunction in 800 hypertensive patients: a multicenter Egyptian national study. Urology (2006) 0.95
The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing. Atherosclerosis (2009) 0.92
Common grounds for erectile dysfunction and coronary artery disease. Curr Opin Urol (2004) 0.92
Do men with mild erectile dysfunction have the same risk factors as the general erectile dysfunction clinical trial population? BJU Int (2010) 0.89
Erectile dysfunction as a predictor of cardiovascular disease. Int J Impot Res (2008) 0.87
Is endothelial function impaired in erectile dysfunction patients? Int J Impot Res (2006) 0.86
The risk of coronary heart disease in men with erectile dysfunction. Eur Urol (2003) 0.86
Prevention of cardiovascular disease by the early identification of erectile dysfunction. Int J Impot Res (2008) 0.85
Erectile dysfunction as a generalized vascular dysfunction. J Am Soc Echocardiogr (2006) 0.84
Pathophysiology of erectile dysfunction. Int J Androl (2003) 0.83
Screening for ischemic heart disease in patients with erectile dysfunction: role of penile Doppler ultrasonography. Urology (2004) 0.82
Erectile dysfunction predicts generalised cardiovascular disease: evidence from a case-control study. Atherosclerosis (2006) 0.81
Surveillance of cardiovascular risk factors for outpatients in different erectile dysfunction severity. Int J Impot Res (2009) 0.80
Erectile dysfunction as a sentinel marker of endothelial dysfunction disease. Singapore Med J (2009) 0.79
Is erectile dysfunction a predictor of cardiovascular events or stroke? A prospective study using a validated questionnaire. Int J Impot Res (2009) 0.79
Prediction of coronary heart disease by erectile dysfunction in men referred for nuclear stress testing. Arch Intern Med (2006) 0.78
Erectile dysfunction: a harbinger or consequence: does its detection lead to a window of curability? J Androl (2010) 0.78
Resiniferatoxin for treatment of lifelong premature ejaculation: a preliminary study. Int J Urol (2014) 2.61
Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate. J Urol (2010) 1.58
Prolonged penile strangulation with metal clamps. Asian J Androl (2006) 1.37
Cancer and sexual problems. J Sex Med (2010) 1.36
Intracavernous transplantation of bone marrow-derived mesenchymal stem cells restores erectile function of streptozocin-induced diabetic rats. J Sex Med (2010) 1.20
Prospective and long-term evaluation of erect penile length obtained with inflatable penile prosthesis to that induced by intracavernosal injection. Asian J Androl (2009) 1.19
Pathophysiology and treatment of diabetic erectile dysfunction. Asian J Androl (2006) 1.10
A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy. J Urol (2012) 1.10
Combined strategy of mesenchymal stem cell injection with vascular endothelial growth factor gene therapy for the treatment of diabetes-associated erectile dysfunction. J Androl (2011) 1.05
Sexual function in chronic illness. J Sex Med (2010) 1.05
Endocrine disruptors and estrogenic effects on male reproductive axis. Asian J Androl (2008) 1.02
Insights of priapism mechanism and rationale treatment for recurrent priapism. Asian J Androl (2008) 1.00
Differential expression of neurotrophins in penises of streptozotocin-induced diabetic rats. J Androl (2006) 0.93
Common approach to managing lower urinary tract symptoms and erectile dysfunction. Asian J Androl (2008) 0.92
The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review. Asian J Androl (2010) 0.91
Molecular mechanisms of vacuum therapy in penile rehabilitation: a novel animal study. Eur Urol (2010) 0.90
Outcomes of simultaneous placement of an inflatable penile prosthesis and a male urethral sling through a single perineal incision. J Sex Med (2009) 0.89
Design and application of a new rat-specific vacuum erectile device for penile rehabilitation research. J Sex Med (2009) 0.86
Penile rehabilitation with a vacuum erectile device in an animal model is related to an antihypoxic mechanism: blood gas evidence. Asian J Androl (2013) 0.86
Simultaneous penile prosthesis and male sling/artificial urinary sphincter. Asian J Androl (2012) 0.84
Varicocele and testicular function. Asian J Androl (2015) 0.84
Effect of caffeine on erectile function via up-regulating cavernous cyclic guanosine monophosphate in diabetic rats. J Androl (2008) 0.83
Treatment strategies for diabetic patients suffering from erectile dysfunction. Expert Opin Pharmacother (2008) 0.83
Initial experience with robot-assisted varicocelectomy. Asian J Androl (2008) 0.81
Losartan, an Angiotensin type I receptor, restores erectile function by downregulation of cavernous renin-angiotensin system in streptozocin-induced diabetic rats. J Sex Med (2008) 0.81
Scale effects on spatially varying relationships between urban landscape patterns and water quality. Environ Manage (2014) 0.80
Treatment strategies for diabetic patients suffering from erectile dysfunction: an update. Expert Opin Pharmacother (2014) 0.80
Can erectile function be predicted after prostate cancer treatment? Asian J Androl (2011) 0.80
COX-2-10aa-PGIS gene therapy improves erectile function in rats after cavernous nerve injury. J Sex Med (2013) 0.80
Mobilisation of endothelial progenitor cells: one of the possible mechanisms involved in the chronic administration of melatonin preventing erectile dysfunction in diabetic rats. Asian J Androl (2012) 0.79
Combination therapy for male erectile dysfunction and urinary incontinence. Asian J Androl (2008) 0.79
The effects of long-term administration of tadalafil on STZ-induced diabetic rats with erectile dysfunction via a local antioxidative mechanism. Asian J Androl (2012) 0.79
The evolution of the inflatable penile prosthetic device and surgical innovations with anatomical considerations. Curr Urol Rep (2014) 0.79
Pressure-induced phase transition in hydrogen-bonded supramolecular adduct formed by cyanuric acid and melamine. J Phys Chem B (2009) 0.78
Combination therapy for erectile dysfunction: an update review. Asian J Androl (2011) 0.78
In vitro and in vivo animal models in priapism research. J Sex Med (2010) 0.77
Overview of contemporary penile rehabilitation therapies. Adv Urol (2008) 0.77
A new strategy, SuperEnzyme gene therapy in penile rehabilitation. J Sex Med (2009) 0.77
[Application of the vacuum erectile device in penile rehabilitation for erectile dysfunction after radical prostatectomy]. Zhonghua Nan Ke Xue (2015) 0.76
Health-related quality of life outcomes in Scandinavian patients after radical prostatectomy or watchful waiting: a critical appraisal. Asian J Androl (2011) 0.75
Comments on "Considerations for diagnostic criteria for erectile dysfunction in DSM-V". J Sex Med (2010) 0.75
Reproducibility analysis on shear wave elastography (SWE)-based quantitative assessment for skin elasticity. Medicine (Baltimore) (2017) 0.75
Evaluation and diagnostic testing of erectile dysfunction in the era of phosphodiesterase type 5 inhibitors. Asian J Androl (2007) 0.75
Men's health is evolving. Asian J Androl (2008) 0.75
Effect of high pressure on the typical supramolecular structure of guanidinium methanesulfonate. J Phys Chem B (2012) 0.75
[Serum high-sensitivity C-reaction protein and heart fatty acid binding protein level and cardiac accidents in patients with unstable angina pectoris]. Zhonghua Xin Xue Guan Bing Za Zhi (2006) 0.75
The International Prostate Forum introduction and history. Asian J Androl (2015) 0.75
Stability of hydrogen-bonded supramolecular architecture under high pressure conditions: pressure-induced amorphization in melamine-boric acid adduct. Langmuir (2009) 0.75
[Clinical application of automated digital image analysis for morphology review of peripheral blood leukocyte]. Zhonghua Yi Xue Za Zhi (2016) 0.75
Combination surgery for erectile dysfunction and male incontinence. Curr Urol Rep (2011) 0.75
[A new method for the detection of platelet derived microparticles by cytometric bead array and its evaluation]. Zhonghua Yi Xue Za Zhi (2005) 0.75
Coffee intake and incidence of erectile dysfunction. Am J Epidemiol (2017) 0.75